Transcript Situational Analysis

E-scripts
Curt Mull
West Holtzclaw
Eric McMath
Cathy Hood
Karen England
Jeff Rund
Kassonga Mwamba
Situational Analysis Recap






5% ( 1.5 million/3.2 billion ) Rx filled incorrectly yearly
Approx. $27 billion could be saved in fewer medication errors
average saving of 0.75 to $3.20 per prescription
50 clinical software venders
Issues include legal, regulatory and consumer adaptation
E-scripts utilizes web-based virtual prescriptions to reduce errors
and increase efficacy in both practices and pharmacies
E-scripts








Web-based, XML, open
Virtual prescriptions
Increase efficiency and decrease prescriptions errors to save lives
Link physicians/pharmacies/HMO/Patient education
Applications across borders
Cost-effective alternative to current systems
Flexible to meet customer needs
Ability to collaborate with companies with ultimate goal of
partnership
Procedure
Physician
Virtual Hub
Pharmaceutical Company
HMO/Medicaid/Medicare
Mail Order
Patient
Pharmacy
Patient advocacy info
Virtual Hub






Web-based
Document Storage
Maintenance of system
Qualification of medications
Location within countries to contain costs
Connectivity to all aspects of clients
Finances

Initial start-up costs


Product Development, Staffing, Legal, compliance,
Working capitol
$2 million
Salaried employees, marketing, outsource
Research Development

$4 million
Alpha/Beta trials
$2 million
Objectives





15% reduction in prescription errors
20% increase in staff efficiency
 (phone calls, re-fills, call backs)
15% Improve prescription fill-time
10% decrease in pharmacy staff
10% reduction in medication cost
Strategic Positioning in U.S.






Small to medium offices that have some type of system in place
Total system implementation or add-ons
Compatibility with government system
Business Solution
Cost-effective alternative to major chain systems
Involvement with HMO/pharmacy/pharmaceutical company
Global Markets







Internet capabilities
Identified prescription errors
Healthcare infrastructure
Financial resources
Understanding of EMR
Government involvement
J.V.
Why U.K./China

China






Government involvement
Realization of situation
Internet applications in metro areas
Lack of knowledge by public regarding medications
Opportunity
U.K.





Need addressed similar to U.S.
Infrastructure in place
Government involvement
Language
Similar Healthcare system
U.K.
Global Market
Assessment
Strengths




Virtual Hub seamless
throughout world
Implementation into foreign
healthcare system
Cost-effective
Location
Weakness



Foreign entity
Resources
Personnel
China
Strengths




System integration seamless
across globe
Flexibility to add-on current
systems
Cost-effective
Location
Weakness



New system development-no
boiler plate
Language
Location
Global Markets
U.K.
U.K.
Opportunity
 Prescription errors higher
than U.S
 Financial means to
implement
 Language
 Healthcare infrastructure
 Government resources
 J.V. opportunity
Threats
 Government push back
 Software incompatibility
 Late to the market
China
Opportunity
 100 Million Internet Users
 Prescription drugs 75% of all
drugs
 Prescription drugs account for
97% of reported adverse
reactions
 Government sponsored
prescription reform
 Internet infrastructure in
metro areas
Threats
 Lack of acceptance in rural
provinces
 Lack of prescription tracking
or history
 Cultural indifference
 I.P. rights
Strategic Implementation - China








Increased focus on prescription tracking and drug interaction
J.V with established healthcare company/pharmacy
Partner with Pharmaceutical Companies and Government
Patient identification and payment system will vary based on
location
Strategic positioning with hospital and local government healthcare
facilities
Initial introduction as enhancement to current practices
Identify and implement total system in ideal setting to maximize
success (i.e. smaller metro physician/hospital system )
Focus on patient education as a means to incorporate system
Strategic Implementation U.K.







Differ than China-quick seamless integration
Infrastructure in place for country-wide implementation
Ramp-up increased by years
Integration into system that will ensure success
Identification of J.V. opportunity with U.K. company
Possible integration with pharmacy chains
Involvement with government to enhance current system in place
5 Year Plan








Development and Implementation in US
Measured objectives
Meet objectives
Begin participation in TQM initiatives
Prepare IPO
Maintain solid performance &
growth in stock price
48-60
Identify J.V. partners outside U.S.
Patent processes (software/business)
36
42
48
48
48
months
months
months
months
months
months
48 months
start
10 Year Plan






Initiate J.V. in identified market outside U.S.
Implement E-scripts through partnerships in UK & China
Realize positive bottom line for global ventures
Maintain goals for prescription fill time based
on market/customer demands
Invest in R&D to move into additional global markets
Expand portfolio into billing services/EMR
Year 5
year 6
year 7
year 8
year 9